|
Status |
Public on Jun 15, 2011 |
Title |
wt prost rep 2 |
Sample type |
RNA |
|
|
Source name |
wt prost
|
Organism |
Mus musculus |
Characteristics |
background strain: C57Bl/6 genotype/variation: wild type age: 30 wks tissue origin: Prostate tissue type: non-tumor
|
Extracted molecule |
total RNA |
Extraction protocol |
RNA was extracted using the guanidinium thiocyanate/cesium chloride gradient method, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
|
Label |
biotin
|
Label protocol |
Biotinylated cRNA were prepared with the Ambion Illumina RNA TotalPrep amplification kit
|
|
|
Hybridization protocol |
Standard Illumina hybridization protocol
|
Scan protocol |
Standard Illumina scanning protocol
|
Description |
replicate 2
|
Data processing |
The data were normalised using quantile normalisation with Illumina BeadStudio Gene Expression Module v3
|
|
|
Submission date |
Jun 14, 2011 |
Last update date |
Jun 15, 2011 |
Contact name |
Paola Pittoni |
E-mail(s) |
[email protected]
|
Phone |
+39 0223903232
|
Fax |
+39 0223902630
|
Organization name |
IRCCS Istituto Nazionale dei Tumori
|
Department |
Dept. Experimental Oncology
|
Lab |
Molecular Immunology Unit
|
Street address |
Via Amadeo, 42
|
City |
Milan |
State/province |
Italy |
ZIP/Postal code |
20133 |
Country |
Italy |
|
|
Platform ID |
GPL6885 |
Series (2) |
GSE29956 |
Gene expression analysis of prostate tumors arisen in TRAMP mice in which mast cells are pharmacologically stabilized or genetically ablated. |
GSE29958 |
Mast cell targeting hampers prostate adenocarcinoma development but promotes the occurrence of highly malignant neuroendocrine cancers. |
|